ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,391,504 | +24.3% | 45,474 | +44.9% | 0.00% | 0.0% |
| Q2 2023 | $1,119,367 | +44.2% | 31,390 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $776,300 | +169.5% | 30,563 | +273.2% | 0.00% | – |
| Q2 2022 | $288,000 | -89.9% | 8,189 | -81.0% | 0.00% | -100.0% |
| Q4 2021 | $2,859,000 | -11.8% | 43,117 | -16.9% | 0.00% | 0.0% |
| Q3 2021 | $3,240,000 | -44.4% | 51,906 | -26.3% | 0.00% | -40.0% |
| Q2 2021 | $5,831,000 | +62.3% | 70,412 | +29.9% | 0.01% | +25.0% |
| Q1 2021 | $3,593,000 | -59.4% | 54,185 | -53.0% | 0.00% | -50.0% |
| Q4 2020 | $8,855,000 | -29.0% | 115,399 | -60.2% | 0.01% | -38.5% |
| Q3 2020 | $12,478,000 | -40.5% | 289,772 | -40.3% | 0.01% | -48.0% |
| Q2 2020 | $20,957,000 | +2.2% | 485,218 | -31.9% | 0.02% | -21.9% |
| Q1 2020 | $20,510,000 | -55.6% | 712,921 | -2.1% | 0.03% | -38.5% |
| Q4 2019 | $46,177,000 | +120.1% | 727,995 | -2.2% | 0.05% | +100.0% |
| Q3 2019 | $20,981,000 | +71.4% | 744,536 | +61.2% | 0.03% | +73.3% |
| Q2 2019 | $12,240,000 | +23.7% | 461,905 | -14.3% | 0.02% | +15.4% |
| Q1 2019 | $9,893,000 | +1832.2% | 539,158 | +1209.1% | 0.01% | +1200.0% |
| Q4 2018 | $512,000 | -60.9% | 41,186 | -39.7% | 0.00% | -50.0% |
| Q3 2018 | $1,309,000 | -15.5% | 68,257 | -40.1% | 0.00% | 0.0% |
| Q2 2018 | $1,549,000 | -75.9% | 113,909 | -87.2% | 0.00% | -77.8% |
| Q1 2018 | $6,430,000 | +49.6% | 891,784 | -23.6% | 0.01% | +50.0% |
| Q4 2017 | $4,298,000 | +2.1% | 1,167,879 | +20.2% | 0.01% | 0.0% |
| Q3 2017 | $4,208,000 | +906.7% | 971,768 | +276.2% | 0.01% | +500.0% |
| Q2 2017 | $418,000 | +162.9% | 258,301 | +200.5% | 0.00% | – |
| Q1 2017 | $159,000 | +57.4% | 85,953 | +31.5% | 0.00% | – |
| Q4 2016 | $101,000 | – | 65,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |